Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Herb/drug interactions

This article was originally published in The Tan Sheet

Executive Summary

Ginseng and ginkgo biloba inhibit CYP3A4 metabolism in study of 22 healthy individuals between ages 21 and 55, Harbor-University of California at Los Angeles investigators state. Six-phase study explored effect of ginseng, ginkgo and St. John's wort on metabolism of Rx antihypertensive drug nifedipine. Confirming previous reports, St. John's wort was found to have an inducing effect on CYP3A4 1("The Tan Sheet" Feb. 14, 2000, p. 19). HIV-1 protease inhibitors are substrates of the CYP3A4 isozyme. "Caution must be exercised when these herbs are combined with medications that are CYP3A4 substrates," M. Smith, MD, et al., stress. Five other posters presented at ASCPT annual meeting examined drug interactions involving St. John's wort

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092307

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel